Cargando…
Acute thrombocytopenia induced by trastuzumab due to complement reaction: A case report
BACKGROUND: The usual treatment option for HER2 breast cancer is targeted therapy with trastuzumab. The common adverse effects of trastuzumab treatment are thrombocytopenia, however, acute thrombocytopenia is rare and its mechanism is still largely unknown. CASE PRESENTATION: We reported a patient w...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763998/ https://www.ncbi.nlm.nih.gov/pubmed/36561721 http://dx.doi.org/10.3389/fmed.2022.1037493 |